Literature DB >> 30610485

Sodium fluorescein-guided brain tumor surgery under the YELLOW-560-nm surgical microscope filter in pediatric age group: feasibility and preliminary results.

Burcu Göker1,2, Talat Kırış3,4.   

Abstract

OBJECTIVE: To evaluate the feasibility and safety of sodium fluorescein (Na-Fl)-guided surgery with the use of the PENTERO 900 surgical microscope (Carl Zeiss, Meditec, Oberkochen, Germany) equipped with the YELLOW-560-nm filter and low-dose Na-Fl (2 mg/kg) in pediatric brain tumor surgery.
METHODS: The study included 23 pediatric patients with various intracranial pathologies, who underwent Na-Fl-guided surgery between April 2015 and February 2018. Clinical features, surgical observations, extent of resection, and tumor histopathology were retrospectively analyzed. The use of YELLOW-560-nm filter was found "helpful" if the discrimination of the pinkish brain tissue and bright yellow stained tumor tissue was clear. Otherwise, it was described as "not helpful."
RESULTS: There were 11 female and 12 male patients with a mean age of 9.4 years. There were 7 brain stem/tectal plate gliomas, 6 supratentorial tumors, 4 intraventricular tumors, 2 pineal tumors, 2 infratentorial tumors, 1 clivus tumor, and 1 tumor with supra- and infratentorial extensions in the current series. Na-Fl was found helpful by means of the tumor demarcation in 20 instances (87%). In 11 of these 20 operations (55%), a total resection was achieved regardless of the tumor pathology. A subtotal resection was achieved in the remaining 9 patients (45%). No adverse events or side effects were encountered with regard to Na-Fl use.
CONCLUSION: Na-Fl guidance with the use of the YELLOW-560 filter is safe and effective during brain tumor surgery in pediatric age group.

Entities:  

Keywords:  Brain tumor; Fluorescence-guided surgery; Pediatric; Sodium fluorescein; Surgical microscope; YELLOW 560

Year:  2019        PMID: 30610485     DOI: 10.1007/s00381-018-04037-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  32 in total

Review 1.  Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review.

Authors:  Pieter L Kubben; Karlien J ter Meulen; Olaf E M G Schijns; Mariël P ter Laak-Poort; Jacobus J van Overbeeke; Henk van Santbrink
Journal:  Lancet Oncol       Date:  2011-08-23       Impact factor: 41.316

2.  Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection.

Authors:  Geirmund Unsgaard; Steinar Ommedal; Tomm Muller; Aage Gronningsaeter; Toril A Nagelhus Hernes
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

3.  Use of Sodium Fluorescein in Meningioma Surgery Performed Under the YELLOW-560 nm Surgical Microscope Filter: Feasibility and Preliminary Results.

Authors:  Mehmet Osman Akçakaya; Burcu Göker; Mustafa Ömür Kasımcan; Mustafa Kemal Hamamcıoğlu; Talat Kırış
Journal:  World Neurosurg       Date:  2017-07-26       Impact factor: 2.104

4.  Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.

Authors:  Daniel Orringer; Darryl Lau; Sameer Khatri; Grettel J Zamora-Berridi; Kathy Zhang; Chris Wu; Neeraj Chaudhary; Oren Sagher
Journal:  J Neurosurg       Date:  2012-09-14       Impact factor: 5.115

5.  Surgical management of single and multiple brain metastases: results of a retrospective study.

Authors:  G Schackert; A Steinmetz; U Meier; S B Sobottka
Journal:  Onkologie       Date:  2001-06

6.  Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective Study.

Authors:  Francesco Acerbi; Claudio Cavallo; Karl-Michael Schebesch; Mehmet Osman Akçakaya; Camilla de Laurentis; Mustafa Kemal Hamamcioglu; Morgan Broggi; Alexander Brawanski; Jacopo Falco; Roberto Cordella; Paolo Ferroli; Talat Kiris; Julius Höhne
Journal:  World Neurosurg       Date:  2017-09-19       Impact factor: 2.104

Review 7.  Surgical treatment of solitary brain metastases.

Authors:  Marilyn Gates; Mohammed Alsaidi; Steven Kalkanis
Journal:  Prog Neurol Surg       Date:  2012-01-06

8.  Use of intraoperative fluorescein sodium fluorescence to improve the accuracy of tissue diagnosis during stereotactic needle biopsy of high-grade gliomas.

Authors:  Roberto Rey-Dios; Eyas M Hattab; Aaron A Cohen-Gadol
Journal:  Acta Neurochir (Wien)       Date:  2014-04-27       Impact factor: 2.216

9.  Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases.

Authors:  Francesco Acerbi; Morgan Broggi; Marica Eoli; Elena Anghileri; Lucia Cuppini; Bianca Pollo; Marco Schiariti; Sergio Visintini; Chiara Orsi; Angelo Franzini; Giovanni Broggi; Paolo Ferroli
Journal:  Acta Neurochir (Wien)       Date:  2013-05-10       Impact factor: 2.216

10.  Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery.

Authors:  Walter Stummer; Thomas Meinel; Christian Ewelt; Peter Martus; Olga Jakobs; Jörg Felsberg; Guido Reifenberger
Journal:  J Neurooncol       Date:  2012-02-04       Impact factor: 4.130

View more
  3 in total

1.  Comprehensive review of surgical microscopes: technology development and medical applications.

Authors:  Ling Ma; Baowei Fei
Journal:  J Biomed Opt       Date:  2021-01       Impact factor: 3.170

2.  Sodium Fluorescein for Spinal Intradural Tumors.

Authors:  Semih Kivanc Olguner; Ali Arslan; Vedat Açık; İsmail İstemen; Mehmet Can; Yurdal Gezercan; Ali İhsan Ökten
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

Review 3.  Effect of 5-Aminolevulinic Acid and Sodium Fluorescein on the Extent of Resection in High-Grade Gliomas and Brain Metastasis.

Authors:  Lasse Cramer Ahrens; Mathias Green Krabbenhøft; Rasmus Würgler Hansen; Nikola Mikic; Christian Bonde Pedersen; Frantz Rom Poulsen; Anders Rosendal Korshoej
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.